2m 2m 2m 2m 2m 2m 2m
GENPREX (GNPX)
NASDAQ
$4.02+$0.06 (+1.65%)
Price as of Aug 21, 2026 7:58 PM EDT- $2.0MMarket Cap
- -97.87%1-Year Change
- BiotechnologyIndustry
GENPREX (GNPX)
$4.02+$0.06 (+1.65%)
GNPX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.95 | ||
Change | $0.00 (0.00%) | ||
Open | $3.90 | ||
High | $4.29 | ||
Low | $3.86 | ||
Previous Close | $3.95 | ||
Volume | 96,475 | ||
30-Day Average Volume | 408,491 | ||
1-Week Change | -8.56% | ||
1-Month Change | -50.66% | ||
1-Year Change | -97.87% | ||
3-Year Change | -99.98% | ||
5-Year Change | -100.00% | ||
Fundamentals | |||
Shares Outstanding | 504,936 | ||
Total Assets | $17.1M | ||
Market Cap | $2.0M | ||
Enterprise Value | -$13.2M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$4.4M | ||
Free Cash Flow | -$5.1M | ||
EBIT | -$4.4M | ||
EBITDA | -$4.4M | ||
Net Working Capital | $13.5M | ||
EPS | -$206.80 | ||
Enterprise Value/EBITDA | 3 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | -0 | ||
PEG | 0 | ||
Price/Free Cash Flow | -0 | ||
Price/Operating Cash Flow | -0 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 22 | ||
Last Split Date | 07/16/2026 | ||
Earnings & Revenue